LND topic: pfizer-novartis page 1

pfizer novartis

Drug Companies Scramble to Join Trump's Pricing Plan

February 12, 2026

Pharmaceutical firms not included in President Trump's drug pricing agreements are now trying to negotiate their own deals. This move is aimed at avoiding potential tariffs and new pricing regulations. Industry insiders reveal that these companies are reaching out to the White House and Medicare off

business

Pharma Powerhouse: Novartis Stock Soars, But Is It a Safe Bet?

January 27, 2026

Novartis, a big name in the medicine world, has seen its stock price hit record highs. Over the past year, shares have jumped nearly 50%. This Swiss company makes a wide range of medicines, from cancer treatments to drugs for immune system disorders. The company's CEO recently said that by mid-2026

health

A Clash of Views: Vaccines, Science, and Global Health Research

January 24, 2026

Albert Bourla, the head of Pfizer, recently shared his thoughts on vaccines and global health research. He had some strong words for Robert F. Kennedy's stance on vaccines, calling it anti-science. Bourla mentioned that while they can talk about other health topics, vaccines are a tough subject. He

health

Why Big Pharma Stocks Might Be the Next Big Thing

January 19, 2026

Healthcare leaders gathered in San Francisco for a major industry event. This conference, known for its massive turnout and high-energy atmosphere, brought together CEOs from big and small drug companies. The buzz was around GLP-1 drugs, which have transformed diabetes and obesity treatment and are

business

Drug Prices: US Companies Pressure Europe for a Change

January 18, 2026

Big US drug companies are pushing Europe to raise their drug prices. They say they might stop sending new medicines to Europe if they don't get what they want. Pfizer's boss, Albert Bourla, said they will stop supplying France if they don't raise their prices. He said they can't accept lower prices

health

Drug Companies Raise Prices Despite Deals

January 16, 2026

Sixteen big drug companies made deals with the Trump administration to lower drug prices. But in January, all of them raised prices on some of their drugs. These deals were supposed to help Americans pay less for medicine and make other rich countries pay more. But according to a new report, these c

business

Big Pharma's Urgent Quest for New Drugs

January 7, 2026

Big Pharma companies are in a rush to buy biotech firms. Why? They face a huge problem. Many of their top-selling drugs will soon lose patent protection. This is called the "patent cliff. " By 2032, they could lose over $170 billion in sales. To avoid this, they need new drugs fast. That's where bi

finance

Guessing the Future of Drugs: A Smart Bet or a Risky Game?

December 26, 2025

The biotech and pharma world is always full of new drugs. But once a drug is out there, how do you know how much it's really worth? This is a big question for companies and investors. A new method has been created to predict future sales using past data. This can help figure out a drug's value today

health

Pfizer's Hympavzi Faces Setback: What You Need to Know

December 26, 2025

Pfizer's stock took a hit recently, and it's all tied to a serious issue with one of their drugs. A patient in a long-term study for Hympavzi, a treatment for hemophilia, passed away due to severe complications. This news came out in December 2025, and it's got people talking. The patient had hemop

finance

Big Pharma Steps Up with Fresh Price Deals

December 26, 2025

Pharmaceutical giants are making headlines again, but this time, it's not about new drugs. Merck and eight other big players have joined Pfizer, Lilly, and Novo in signing Most Favored Nation (MFN) deals. These agreements aim to make medicines more affordable by tying drug prices to the lowest price